journal article·2015-11

Hydrolysis‐Sensitive Dithiolethione Prodrug Micelles

Urara Hasegawa, Naoya Tateishi, Hiroshi Uyama, André J. van der Vlies

Macromolecular Bioscience· Volume 15· Issue 11
Publisher page

Abstract

Prodrug micelles carrying 5‐(4‐hydroxyphenyl)‐3H‐1,2‐dithiole‐3‐thione (ADT‐OH), a compound possessing chemopreventive properties, are prepared from amphiphilic block copolymers linking ADT‐OH via an ester bond using glycine (PAM‐PGlyADT) and isoleucine linkers (PAM‐PIleADT). The release of ADT‐OH from the PAM‐PIleADT micelles is much slower than the PAM‐PGlyADT micelles. The PAM‐PGlyADT micelles show comparable toxicity with ADT‐OH in different cancer cell lines, whereas the PAM‐PIleADT micelles are not toxic up to 400 µM. This ADT‐ester prodrug micelle approach enables to modulate the release rate of ADT‐OH and thus might find application in cancer therapy and prevention.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Metal-Organic Frameworks: Synthesis and Applications · Sulfur Compounds in Biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Frontier Research Base for Young Researchers and Department of Applied Chemistry Graduate School of Engineering Osaka University 2‐1 Yamadaoka Suita Osaka 565‐0871 Japan

Department of Applied Chemistry Graduate School of Engineering Osaka University 2‐1 Yamadaoka Suita Osaka 565‐0871 Japan

Frontier Research Center and Department of Applied Chemistry Graduate School of Engineering Osaka University 2‐1 Yamadaoka Suita Osaka 565‐0871 Japan

Funding

Grant-in-Aid for Challenging Exploratory Research

References (27)

Show source-provided references
1. 10.1158/1535-7163.MCT-08-062510.1158/1535-7163.MCT-08-0625 ↗
2. Reddy B. S. · Cancer Res. · 1993 · 53 · 3493
3. 10.1007/s00702-005-0350-010.1007/s00702-005-0350-0 ↗
4. 10.1016/S0027-5107(01)00190-710.1016/S0027-5107(01)00190-7 ↗
5. 10.1074/jbc.M21189820010.1074/jbc.M211898200 ↗
6. Christen M. O. · 1995 · 324
7. Christen M.‐O. · 1995 · 316
8. 10.1038/nrd242510.1038/nrd2425 ↗
9. 10.1021/bc500150s10.1021/bc500150s ↗
10. 10.1016/j.bcp.2011.12.01810.1016/j.bcp.2011.12.018 ↗
11. 10.1039/c3md00362k10.1039/c3md00362k ↗
12. 10.1021/jm100425v10.1021/jm100425v ↗
13. 10.1038/nrd108810.1038/nrd1088 ↗
14. 10.1002/polc.507051011110.1002/polc.5070510111 ↗
15. 10.1016/0378-5173(92)90176-310.1016/0378-5173(92)90176-3 ↗
16. 10.1038/nrc195810.1038/nrc1958 ↗
17. 10.1021/bc00016a00710.1021/bc00016a007 ↗
18. 10.1016/S0065-2571(00)00013-310.1016/S0065-2571(00)00013-3 ↗
19. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
20. Jorgensen K. E. · Am. J. Physiol. · 1979 · 236 · F10310.1152/ajpcell.1979.236.3.C103 ↗
21. 10.1002/adhm.20140024910.1002/adhm.201400249 ↗
22. 10.1016/j.freeradbiomed.2006.12.01110.1016/j.freeradbiomed.2006.12.011 ↗
23. 10.1016/j.polymer.2015.03.08010.1016/j.polymer.2015.03.080 ↗
24. 10.1021/ja107502510.1021/ja1075025 ↗
25. 10.1016/0006-291X(86)91029-610.1016/0006-291X(86)91029-6 ↗
26. 10.1016/j.bmc.2010.06.08410.1016/j.bmc.2010.06.084 ↗
27. 10.1158/0008-5472.CAN-11-311510.1158/0008-5472.CAN-11-3115 ↗